WalletHub: 5 best chip and pin credit cards
In a WalletHub story identifying the best chip and pin credit cards for consumers, Cincinnati Law’s Susan Stephan, Director of the MLS Program, provided expert commentary about the adoption of chip and pin credit cards in the United States.
“The adoption of chip-and-PIN credit cards has been relatively slow in the U.S., particularly compared to other countries including Canada, Japan, and - notably - the European Union,” said Stephan. “Although more secure than chip and signature cards that still dominate the U.S., upgrading payment systems to support chip-and-PIN can be expensive for businesses, and there has not yet been a significant consumer push for the technology.”
A chip and PIN credit card is a card that contains a small computer chip and gives users a 4-digit personal identification number (PIN) to enter when making purchases. Chip and PIN credit cards provide improved security compared to chip and signature cards and magnetic stripe cards.
In the WalletHub article, Stephan also addressed the biggest misconceptions about “chip” cards, using the cards internationally, and the safety of chip and pin cards versus other types.
Read Stephan’s full interview: "5 Best Chip and Pin Credit Cards".
Lead photo: istockphoto.com
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.